By Janice MacLennan, CEO Claroo Ltd and pharma strategy expert.
Our today is not as we would have envisaged five years ago. Hybrid working and remote meetings are the norm, but business technology is still struggling to catch up.
While the pandemic saw a rocket in popularity for platforms such as Zoom, no alternative has been offered for strategy. We can meet online, we can collaborate remotely, but how do we facilitate better decision-making, capture inputs and track the outcomes of these meetings?
Strategy platforms for business
When a team in the US confers with their Asian counterparts, time zones are crossed and notes are taken, but storing the outcome of the discussion all in one place can be time consuming, inaccurate and laborious, and the risk of losing or burying a crucial piece of input is high.
If only there were a platform where teams could strategise together, spanning time zones and continents, which would record every individual team member’s input, and enable everyone to work cohesively on the same strategy.. A step up from sharing documents, and adding to calendar, what would change our tomorrow would be a business innovation that allowed companies to do this.
One of 2022’s most exciting technology innovations, NMBLR, claims to do just that.
NMBLR is a first-to-market strategy platform which works to enable teams to work together across geographical locations and time zones.
Pharma and beyond
Created initially for the pharma industry by life sciences expert Janice MacLennan, NMBLR was built by digital experts Neverbland at a cost of more than £1million and using the experience of MacLennan’s 30+ years developing strategy for global pharma giants. The platform is for mid-sized pharma/biotech companies to enable them to bring innovations to market more swiftly, productively and for greater commercial success.
NMBLR facilitates hybrid working like nothing else. Teams from all corners of the globe can strategise as if they were in the same room, and a digital trail is recorded every step of the way. It is set to transform how global business develops their commercialisation strategy and was recently listed at number 2 in the 50 most important Health Tech innovations of 2022.
Innovations that truly shape our tomorrow must be agile and reactive, take video conferencing solutions for outside-of-home offices for example. Outside-of-home offices are evolving to accommodate post-pandemic working; instead of open-floor-plan designs for lots of people, they are being transformed into social spaces and smaller meeting rooms. The office is becoming a place to discuss the work, not do the work. Video conferencing technology has responded – one can now bring video conferencing to private homes, huddle rooms and large conference rooms.
What makes an innovation stand out?
During a recent webinar, What makes a health tech innovation stand out? [let’s link to a LinkedIn post on this] it was interesting to hear from investors and designers about what they seek and strive for when assessing a new innovation.
An innovation needs to create value as perceived through the eyes of the stakeholder. This will truly form an innovation that shapes our tomorrow.
Different stakeholders value different things. These are varied and address myriad issues. Considered values may include whether the idea tackles a global issue, and how urgent is the problem that the innovation claims to be solving? Investors will want to see solid data behind an idea, and evidence that it actually works. Ideas are all well and good, but people need proof before backing. Lastly, they may ask how quickly the platform is being adopted, and what the level of engagement is.
NMBLR has been hailed by many testers as revolutionary, and MacLennan already uses it with global pharma clients, a sign that its future core value could prove immeasurable.
For any innovation, once these questions are answered and its true value is assessed and validated, only then can creators move forward to bring something to market that will truly have an impact on our future.